Multiple sclerosis in 2016: Immune-directed therapies in MS - efficacy and limitations

Nat Rev Neurol. 2017 Feb;13(2):72-74. doi: 10.1038/nrneurol.2017.2. Epub 2017 Jan 20.

Authors

Bernhard Hemmer¹, Mark Mühlau²

Affiliations

¹ Department of Neurology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Strasse 22, 81675 Munich, Germany and affiliated with the Cluster for Systems Neurology (SyNergy).
² Department of Neurology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Strasse 22, 81675 Munich, Germany and affiliated with the TUM-Neuroimaging Center (TUM-NIC).

PMID: 28106067
DOI: 10.1038/nrneurol.2017.2

No abstract available

Publication types

Review

MeSH terms

Hematopoietic Stem Cell Transplantation / methods
Humans
Immunotherapy / methods
Multiple Sclerosis / therapy*